Catalog Products » SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag)

SARS-CoV-2 Nucleocapsid S-RBD Fusion (His Tag)

*This product has been discontinued!*
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. SARS-CoV-2 Spike Protein (RBD) also has the potential value for the diagnosis of the virus.
Z03505
Ask us a question
Product Introduction
Species SARS-CoV-2
Protein Construction

Full length of nucleocapsid protein and spike protein RBD region.

N-RBD Fusion (Full length)
Accession # P0DTC2 & P0DTC9		 Poly-His
N-term C-term
Purity > 75% as analyzed by SDS-PAGE
Endotoxin Level < 0.2 EU/μg of protein by gel clotting method
Biological Activity SARS-CoV-2 Nucleocapsid S-RBD Fusion (His tag) can bind to both human ACE2 (Cat. No.: Z03484) and nucleocapsid antibody (Cat. No.: A02039) in functional ELISA assay.
Expression System 293 Cells
Theoretical Molecular Weight 74.9 kDa
Formulation Supplied as a solution in PBS pH 7.4 containing 10% glycerol.
Concentration Please refer to the COA for the specific lot.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles.

Background
Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. SARS-CoV-2 Spike Protein (RBD) also has the potential value for the diagnosis of the virus.
Synonyms N+RBD; SARS-CoV-2 S-RBD+N protein; 2019-nCoV S-RBD+N protein; SARS-CoV-2 NP S-RBD fusion

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.